**Core Concept**
Osteomalacia is a condition characterized by the softening of bones due to impaired bone mineralization. It is often caused by deficiency of vitamin D, calcium, or phosphate, leading to inadequate bone matrix calcification. The condition is common in individuals with disorders affecting vitamin D metabolism or those with impaired renal function.

**Why the Correct Answer is Right**
The correct answer is **A. Phenytoin**. Phenytoin is an antiepileptic medication known to interfere with vitamin D metabolism, leading to osteomalacia. It induces the enzyme responsible for the conversion of 25-hydroxyvitamin D to its active form, 1,25-dihydroxyvitamin D. This results in decreased levels of active vitamin D, impairing bone mineralization and leading to osteomalacia.

**Why Each Wrong Option is Incorrect**
**Option B:** **Chloramphenicol** is an antibiotic that can affect bone metabolism but is not primarily associated with osteomalacia. It can cause bone marrow suppression, which may lead to osteoporosis or other bone disorders.

**Option C:** **Corticosteroids** can cause osteoporosis due to their effects on bone resorption and mineralization. However, they are not directly implicated in the causation of osteomalacia.

**Option D:** **Isoniazid** is an antitubercular medication that can interfere with vitamin B6 metabolism, leading to peripheral neuropathy. It is not directly associated with osteomalacia.

**Clinical Pearl / High-Yield Fact**
Phenytoin-induced osteomalacia can be prevented by administering calcium and vitamin D supplements to patients on long-term phenytoin therapy.

**Correct Answer:** A. Phenytoin